Expert urges Alabama task force to add comprehensive obesity care to state employee and Medicaid plans
Loading...
Summary
Dr. Saunders told the Joint Interim Committees that Alabama should expand coverage of intensive behavioral therapy, FDA‑approved obesity medications and bariatric surgery in the state employee health plan and Medicaid, while emphasizing that implementation (provider training, monitoring and prior‑authorization reform) is critical to avoid waste and achieve health and cost benefits.
Representative Oliver opened the session by reading a statement from the OPCD Action Coalition urging the task force to recommend coverage of comprehensive obesity care, including intensive behavioral therapy, FDA‑approved obesity medications and metabolic and bariatric surgery under the state employee health plan and Medicaid.
Dr. R. Saunders, an obesity medicine physician affiliated with Weill Cornell and a co‑founder of a clinical cardiometabolic services company, told the Joint Interim Committees that obesity is a chronic disease and that coverage should include medications as well as behavioral and surgical options. "Obesity is a serious chronic disease that requires treatment and management like diabetes, cancer, or high blood pressure," Saunders said, arguing care must be medical, not moralizing.
Saunders cautioned that coverage alone will not guarantee improved outcomes. She said the key to value is implementation that keeps patients on therapy and pairs medications with comprehensive, acuity‑based teams and monitoring. She cited a Milliman analysis of a Connecticut pilot showing high adherence and cost avoidance and described the recent White House and CMS announcements as potentially helpful to reduce prices and allow Medicaid to engage manufacturers on discounts.
Task force members pressed on details that affect coverage decisions: how prescribing should be overseen, who should be authorized to manage therapy, and whether prior‑authorization rules will align with clinical guidelines. Saunders said programs that are "gold‑carded" (trusted providers with streamlined authorization) and that include training for primary care clinicians are promising ways to scale care without overprescribing.
No formal motion or vote was taken at the meeting. The task force heard requests from the OPCD Action Coalition and an expert presentation from Dr. Saunders and discussed next steps including gathering pilot reports and clarifying prior‑authorization and monitoring requirements before making formal coverage recommendations.
